INDSWFTLABUpdated 3 Sept 2026, 6:15

Ind Swift Laboratories Lt

INDSWFTLABUpdated 3 Sept 2026, 6:15

Market Cap

₹3,190Cr.

Current Price

₹367

High / Low

₹390/87.0

Stock P/E

47.7

ROE4.00%

ROCE4.83%

Book Value₹158

Face Value₹10.0

Dividend Yield0.00%

About

Incorporated in 1995, Ind-Swift LaboratoriesLtd is a pharmaceutical company focusedon finished dosage formulations (FDF). Co. manufactures tablets, capsules, ointments, injectables, liquids and dry syrups across therapies including gynaecology, paediatrics, cardiology, diabetology and dermatology. Operations span domestic formulationsand international markets through ownbrands, contract manufacturing and out-licensing.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	212	205	179	191	168	187	171	158	149	56	106	108
Inventory Days	319	377	317	305	302	330	304	303	253	28	137	184
Days Payable	119	137	88	112	110	122	106	120	114	114	141	185
Cash Conversion Cycle	412	445	409	384	359	395	368	342	287	-30	102	107
Working Capital Days	32	-35	-106	-59	225	256	243	249	226	-7	83	120
ROCE %	1%	2%	2%	3%	4%	5%	7%	7%	13%	21%	1%	5%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 3 September 2026 at 6:15

IND SWIFT LABORATORIES LT (INDSWFTLAB) financials — quarterly results, P&L, cash flow, balance sheet, shareholding